Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Priya Rastogi

10PUBLICATIONS
102CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jun 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual disease.

|Dec 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Yara Abdou, William E Barlow, Julie R Gralow

|Aug 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials.

Julia Foldi, Neil Carleton, Stewart J Anderson

|Jul 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Jun 04, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai

|Feb 20, 2024
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi

Pageof 2

Frequent Collaborators

5 joint publications

Charles E Geyer

4 joint publications

Norman Wolmark

4 joint publications

Eleftherios P Mamounas

3 joint publications

Priyanka Sharma

3 joint publications

Adam M Brufsky

3 joint publications

Soonmyung Paik

3 joint publications

Sandra M Swain

2 joint publications

Greg Yothers

2 joint publications

Patricia A Ganz

2 joint publications

Matthew P Goetz

Frequent Collaborators

5 joint publications

Charles E Geyer

4 joint publications

Norman Wolmark

4 joint publications

Eleftherios P Mamounas

3 joint publications

Priyanka Sharma